In a study, 94% of men with inflammatory bowel disease had erectile dysfunction.
Men with gallbladder stone disease have a 40% increased risk of organic erectile dysfunction compared with men who do not have the disease.
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
Investigators using a bone-seeking radiopharmaceutical show for the first time that atherosclerosis in penile arteries is associated with an increased risk of erectile dysfunction.
People with psoriasis have physical and psychological comorbidities that are associated with a higher risk for sexual dysfunction.
Sildenafil and tadalafil not approved to be sold over the counter and are being sold illegally.
New study reveals a 29% prevalence of erectile dysfunction, a proportion higher than that of the general population.
Men prescribed 3 different phosphodiesterase type 5 inhibitors had nearly 3-fold increased odds of having a Charlson Comorbidity Index of 1 or higher than men not prescribed the drugs.
Data show that gout is associated with an increased risk of developing erectile dysfunction.
Collagenase clostridium histolyticum therapy is associated with significantly worse improvement in penile curvature in men with calcified plaques.